Published in Am J Physiol on October 01, 1991
Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev (2007) 6.53
Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes (2000) 4.80
The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest (1999) 1.72
Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest (1993) 1.35
Loss of hepatic autoregulation after carbohydrate overfeeding in normal man. J Clin Invest (1995) 1.16
PCB 126 and other dioxin-like PCBs specifically suppress hepatic PEPCK expression via the aryl hydrocarbon receptor. PLoS One (2012) 1.06
Alterations in hepatic glucose and energy metabolism as a result of calorie and carbohydrate restriction. Hepatology (2008) 0.97
Comparison of the direct and indirect effects of epinephrine on hepatic glucose production. J Clin Invest (1997) 0.93
The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues. J Clin Invest (1995) 0.87
Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetes. Diabetologia (2008) 0.78
Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology (1986) 4.89
Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion. Diabetes (1970) 3.12
Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest (1975) 2.04
A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab (1991) 1.96
17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss. J Clin Endocrinol Metab (1997) 1.83
Adrenergic receptor control mechanism for growth hormone secretion. J Clin Invest (1968) 1.60
Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril (2001) 1.28
Down regulation of insulin receptors in primary cultures of adult rat hepatocytes in monolayer. Endocrinology (1978) 1.27
Portal and peripheral vein immunoreactive glucagon concentrations after arginine or glucose infusions. Diabetes (1974) 1.23
Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab (1989) 1.16
Loss of hepatic autoregulation after carbohydrate overfeeding in normal man. J Clin Invest (1995) 1.16
Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab (1988) 1.14
Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia. J Clin Invest (1979) 1.11
Stimulatory effect of exogenous catecholamines on plasma HGH concentrations in presence of beta adrenergic blockade. Metabolism (1970) 1.10
Sleep-associated fall in glucose disposal and hepatic glucose output in normal humans. Putative signaling mechanism linking peripheral and hepatic events. Diabetes (1989) 1.09
Insulin-secreting bronchial carcinoid tumor with widespread metastases. Am J Med (1968) 1.08
Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metab (2001) 1.02
Perifusion of pancreas fragments. A system for the study of dynamic aspects of insulin secretion. Diabetes (1974) 1.00
The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab (1999) 0.98
Evidence for increased liver glycogen in patients with noninsulin-dependent diabetes mellitus after a 3-day fast. J Clin Endocrinol Metab (1992) 0.97
Central nervous system insulin receptors in normal and diabetic rats. Endocrinology (1979) 0.96
Effect of weight loss by a low-fat diet and a low-carbohydrate diet on peptide YY levels. Int J Obes (Lond) (2010) 0.96
The metabolic syndrome in polycystic ovary syndrome. J Endocrinol Invest (2006) 0.95
Portal vein insulin concentrations in diabetic subjects. Diabetes (1971) 0.95
Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance? J Clin Endocrinol Metab (1993) 0.94
Effect of lithium on pancreatic islet insulin release. Endocrinology (1978) 0.93
Uptake of gold- and [3H]cholesteryl linoleate-labeled human low density lipoprotein by cultured rat granulosa cells: cellular mechanisms involved in lipoprotein metabolism and their importance to steroidogenesis. J Cell Biol (1985) 0.92
Insulin-lowering drugs in polycystic ovary syndrome. Obstet Gynecol Clin North Am (2001) 0.92
Effect of lipids on growth hormone secretion in humans. J Clin Invest (1971) 0.92
Effect of lipid and ketone infusions on insulin-induced growth hormone elevations in rhesus monkeys. Endocrinology (1969) 0.91
The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. J Clin Endocrinol Metab (1987) 0.91
Hyperinsulinism in endotoxin shock dogs. Metabolism (1976) 0.90
Disparate effects of insulin reduction with diltiazem on serum dehydroepiandrosterone sulfate levels in obese hypertensive men and women. J Clin Endocrinol Metab (1994) 0.90
Detection of vitamin D binding protein on the surface of cytotrophoblasts isolated from human placentae. Endocrinology (1987) 0.89
Dehydroepiandrosterone: the "missing link" between hyperinsulinemia and atherosclerosis? FASEB J (1992) 0.89
An effect of hyposmolarity on insulin release in vitro. Am J Physiol (1975) 0.89
Evidence for dual control mechanism regulating hepatic glucose output in nondiabetic men. Diabetes (1991) 0.88
Suppression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of possible mechanisms. J Clin Endocrinol Metab (1989) 0.87
Metabolism of high density lipoproteins reconstituted with [3H]cholesteryl ester and [14C]cholesterol in the rat, with special reference to the ovary. Endocrinology (1985) 0.86
Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome. J Endocrinol Invest (2008) 0.86
Galactorrhea-amenorrhea syndrome: follow-up of forty-five patients after pituitary tumor removal. Ann Intern Med (1981) 0.86
Hemochromatosis and pruritus. Ann Intern Med (1983) 0.85
Metabolism and actions of dehydroepiandrosterone in humans. J Steroid Biochem Mol Biol (1991) 0.85
Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation. Circulation (1993) 0.84
Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes. Diabetes Care (2001) 0.84
Suppression of serum insulin level by diazoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy, nonobese women. Am J Obstet Gynecol (1990) 0.84
Failure of a midnocturnal insulin infusion to suppress the increased insulin need for breakfast in insulin-dependent diabetic patients. Diabetes (1984) 0.84
The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome. Am J Obstet Gynecol (1989) 0.84
Pump-induced insulin aggregation. A problem with the Biostator. Diabetes (1985) 0.84
Insulin inhibits adrenal 17,20-lyase activity in man. J Clin Endocrinol Metab (1992) 0.83
Effect of streptozotocin on qualitative aspects of plasma insulin in a patient with a malignant islet cell tumor. J Clin Endocrinol Metab (1970) 0.83
Lack of effect of dehydroepiandrosterone in obese men. Int J Obes (1990) 0.83
Hypoglycemic potential of nateglinide versus glyburide in patients with type 2 diabetes mellitus. Metabolism (2004) 0.82
Suppression of gluconeogenesis after a 3-day fast does not deplete liver glycogen in patients with NIDDM. Diabetes (1994) 0.82
Interleukin-1 is induced in the human placenta by endotoxin and isolation procedures for trophoblasts. J Clin Endocrinol Metab (1992) 0.82
Dehydroepiandrosterone inhibits human platelet aggregation in vitro and in vivo. Ann N Y Acad Sci (1995) 0.81
Metformin and the polycystic ovary syndrome. J Clin Endocrinol Metab (2001) 0.81
The surface structure of isolated pancreatic islet cells. Cell Tissue Res (1975) 0.81
Hypoglycemia during pregnancy following pancreatoduodenectomy. Metabolism (1971) 0.81
Effect of lipids on glucagon secretion in man. Metabolism (1975) 0.80
Effect of dietary composition on insulin receptors in normal subjects. Am J Clin Nutr (1979) 0.80
Effects of extreme hyperinsulinaemia on serum levels of trace metals, trace metal binding proteins, and electrolytes in normal females. Acta Endocrinol (Copenh) (1987) 0.80
Effect of adrenergic receptor blackade on nicotinic acid-induced plasma FFA rebound. Metabolism (1969) 0.80
Skeletal muscle lipids and glycogen mask substrate competition (Randle cycle). Metabolism (1993) 0.80
Changes in phosphatidylcholine fatty acid composition are associated with altered skeletal muscle insulin responsiveness in normal man. Metabolism (2000) 0.79
Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance. Panminerva Med (2008) 0.79
The insulin-like growth factor, somatomedin-C, modulates low density lipoprotein metabolism by swine granulosa cells. Endocrinology (1987) 0.79
Skeletal muscle phosphatidylcholine fatty acids and insulin sensitivity in normal humans. Am J Physiol (1998) 0.79
Absorption characteristic of breakfast determines insulin sensitivity and carbohydrate tolerance for lunch. Diabetes Care (1989) 0.79
Accelerated decline in hepatic glucose production during fasting in normal women compared with men. Metabolism (1989) 0.79
Role of ERCP in asymptomatic orthotopic liver transplant patients with abnormal liver enzymes. Am J Gastroenterol (2000) 0.79
Insulin secretion in hypothermic dogs. Am J Physiol (1967) 0.78
Downregulation of insulin receptors in obese man. Diabetes (1979) 0.78
Effect of down-regulation of insulin receptors on receptor-antibody binding. Endocrinology (1981) 0.78
Morning insulin requirements. Critique of dawn and meal phenomena. Diabetes (1989) 0.78
Endoscopic removal of a "floating" biliary Gianturco Z stent five years after placement for a benign anastomotic stricture in a liver transplant patient. Gastrointest Endosc (1997) 0.78
Mechanisms of action of diazoxide. J Lab Clin Med (1967) 0.78
Adrenergic control mechanism for vasopressin-induced plasma growth hormone response. Metabolism (1968) 0.78
Persistent defect in regulation of prolactin secretion after successful pituitary tumor removal in women with the galactorrhea-amenorrhea syndrome. J Clin Endocrinol Metab (1980) 0.78
Stimulation of rat ovarian cell steroidogenesis by high density lipoproteins modified with tetranitromethane. J Biol Chem (1985) 0.77
Impaired modulation of hepatic glucose output overnight after a 72-h fast in normal man. J Clin Endocrinol Metab (1990) 0.77
Effect of insulin on serum levels of dehydroepiandrosterone metabolites in men. Clin Endocrinol (Oxf) (1997) 0.77
Relation of serum molindone levels to serum prolactin levels and antipsychotic response. J Clin Psychiatry (1989) 0.77
Polycystic ovary syndrome: a disorder for the generalist. Fertil Steril (1998) 0.77
The neuroendocrine and behavioral response to dextroamphetamine in normal individuals. Biol Psychiatry (1984) 0.77
Radioimmunoassay of the A-chain of insulin. Diabetes (1967) 0.77
The calcium channel blocker amlodipine raises serum dehydroepiandrosterone sulfate and androstenedione, but lowers serum cortisol, in insulin-resistant obese and hypertensive men. J Clin Endocrinol Metab (1993) 0.77
Dehydroepiandrosterone reduces plasma plasminogen activator inhibitor type 1 and tissue plasminogen activator antigen in men. Am J Med Sci (1996) 0.77